Advanced search
Publication Cover
Expert Opinion on Drug Delivery Volume 18, 2021 - Issue 11
Submit an article Journal homepage
675
Views
15
CrossRef citations to date
0
Altmetric
Technology Evaluation

Port delivery system: a novel drug delivery platform to treat retinal diseases

Arshad M. Khanania Sierra Eye Associates, Reno, NV, USA;b University of Nevada, Reno School of Medicine, Reno, NV, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8928-5599View further author information
ORCID Icon,
Aamir A. Aziza Sierra Eye Associates, Reno, NV, USA;b University of Nevada, Reno School of Medicine, Reno, NV, USAORCID Iconhttps://orcid.org/0000-0002-3657-4861View further author information
ORCID Icon,
Christina Y. Wengc Department of Ophthalmology, Cullen Eye Institute, Baylor College of Medicine, Houston, TX, USAView further author information
,
Weijie Violet Lind Department of Ophthalmology, Harkness Eye Institute, Columbia University Medical Center, New York, NY, USAORCID Iconhttps://orcid.org/0000-0002-1894-4267View further author information
ORCID Icon,
Jordyn Vannavonga Sierra Eye Associates, Reno, NV, USAView further author information
,
Jay Chhablanie Department of Ophthalmology, UPMC Eye Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USAORCID Iconhttps://orcid.org/0000-0003-1772-3558View further author information
ORCID Icon,
Carl J. Danzigf Rand Eye Institute, Deerfield Beach, FL, USA;g Florida Atlantic University, Boca Raton, FL, USAView further author information
&
Peter K. Kaiserh Cole Eye Institute, Cleveland Clinic, Cleveland, OH, USAORCID Iconhttps://orcid.org/0000-0001-5126-045XView further author information
ORCID Icon show all
Pages 1571-1576 | Received 09 Jun 2021, Accepted 12 Aug 2021, Published online: 24 Aug 2021

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Sofía M. Muns, Victor M. Villegas, Harry W. Flynn$suffix/text()$suffix/text() & Stephen G. Schwartz. (2023) Update on current pharmacologic therapies for diabetic retinopathy. Expert Opinion on Pharmacotherapy 24:14, pages 1577-1593.
Read now
Shrirang V. Ranade, Mark R. Wieland, Tammy Tam, Jennifer C. Rea, Judit Horvath, Aaron R. Hieb, Weitao Jia, Lori Grace, Giulio Barteselli & Jay M. Stewart. (2022) The Port Delivery System with ranibizumab: a new paradigm for long-acting retinal drug delivery. Drug Delivery 29:1, pages 1326-1334.
Read now
Matthew N. O’Brien Laramy & Karthik Nagapudi. (2022) Long-acting ocular drug delivery technologies with clinical precedent. Expert Opinion on Drug Delivery 19:10, pages 1285-1301.
Read now

Articles from other publishers (12)

Weiye Li & Jingfa Zhang. 2024. Therapeutic Targets for Diabetic Retinopathy. Therapeutic Targets for Diabetic Retinopathy 215 263 .
Chaerim Kang, John C Lin, Helen Zhang, Ingrid U Scott, Jayashree Kalpathy-Cramer, Su-Hsun Liu & Paul B Greenberg. (2023) Artificial intelligence for diagnosing exudative age-related macular degeneration. Cochrane Database of Systematic Reviews 2023:1.
Crossref
Anisha Anand, Hong-Jyuan Jian, Hao-Hsin Huang, Li Er Hean, Yu-Jia Li, Jui-Yang Lai, Hung-Da Chou, Yu-Chuan Kang, Wei-Chi Wu, Chi-Chun Lai, Chih-Ching Huang & Huan-Tsung Chang. (2023) Anti-angiogenic carbon nanovesicles loaded with bevacizumab for the treatment of age-related macular degeneration. Carbon 201, pages 362-370.
Crossref
G. Gedik, C. K. Oztabag, O. Sarp, H. Nazli, G. Tiranbesli, A. H. Kurt, E. Dinc & L. Ayaz. (2022) Development of Anti-VEGF Prolonged Release Drug Delivery System Containing PLL Dendrimer and Hyaluronic Acid. Russian Journal of Bioorganic Chemistry 48:6, pages 1348-1361.
Crossref
James H.B. Im, Ya-Ping Jin, Ronald Chow, Riddhi Shah Dharia & Peng Yan. (2022) Delayed anti-VEGF injections during the COVID-19 pandemic and changes in visual acuity in patients with three common retinal diseases: A systematic review and meta-analysis. Survey of Ophthalmology 67:6, pages 1593-1602.
Crossref
Lucas Ribeiro, Juliana Oliveira, Dante Kuroiwa, Mohamed Kolko, Rodrigo Fernandes, Octaviano Junior, Nilva Moraes, Huber Vasconcelos, Talita Oliveira & Mauricio Maia. (2022) Advances in Vitreoretinal Surgery. Journal of Clinical Medicine 11:21, pages 6428.
Crossref
Jingfa Zhang, Jingxiang Zhang, Chaoyang Zhang, Jingting Zhang, Limin Gu, Dawei Luo & Qinghua Qiu. (2022) Diabetic Macular Edema: Current Understanding, Molecular Mechanisms and Therapeutic Implications. Cells 11:21, pages 3362.
Crossref
Thomas Waterkotte, Xingyu He, Apipa Wanasathop, S. Kevin Li & Yoonjee C. Park. (2022) Long-Term Antibody Release Polycaprolactone Capsule and the Release Kinetics in Natural and Accelerated Degradation. ACS Biomaterials Science & Engineering 8:10, pages 4428-4438.
Crossref
Atul Garkal, Priyanka Bangar, Amarjitsing Rajput, Prashant Pingale, Namdev Dhas, Anam Sami, Khushboo Mathur, Shubham Joshi, Sonika Dhuri, Dhaivat Parikh, Srinivas Mutalik & Tejal Mehta. (2022) Long-acting formulation strategies for protein and peptide delivery in the treatment of PSED. Journal of Controlled Release 350, pages 538-568.
Crossref
Blessing C. Ilochonwu, Marko Mihajlovic, Roel F. Maas-Bakker, Charis Rousou, Miao TangMei ChenWim E. Hennink & Tina Vermonden. (2022) Hyaluronic Acid-PEG-Based Diels–Alder In Situ Forming Hydrogels for Sustained Intraocular Delivery of Bevacizumab . Biomacromolecules 23:7, pages 2914-2929.
Crossref
Flavio A. Rezende. (2022) O retinólogo cirúrgico. Revista Brasileira de Oftalmologia 81.
Crossref
Aira Sarkar, Vijayabhaskarreddy Junnuthula & Sathish Dyawanapelly. (2021) Ocular Therapeutics and Molecular Delivery Strategies for Neovascular Age-Related Macular Degeneration (nAMD). International Journal of Molecular Sciences 22:19, pages 10594.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.